REG - Titon Holdings PLC - Admission to trading on AIM

Titon HoldingsAnnouncement

10/12/2018 07:00

RNS Number : 8005J
Titon Holdings PLC
10 December 2018
 


10 December 2018
Titon Holdings plc     
Admission to trading on AIM
Further to the announcement on 9 November 2018, Titon Holdings plc ("Titon" or the "Company") is pleased to confirm that admission of its ordinary shares of 10 pence each ("Ordinary Shares") to trading on the AIM market of the London Stock Exchange will take place at 8.00am today ("Admission"). At the same time, the admission of the Ordinary Shares to the premium listing segment of the Official List and to trading on the Main Market will be cancelled. The ordinary shares will continue to trade under the TIDM "TON".
Disclosures as required by AIM Rule 26 can be found at: http://www.titonholdings.com/pages/shareholder-info/aim-rule-26-information.php 
The Company's issued share capital comprises 11,133,750 Ordinary Shares, each carrying the right to one vote. The Company holds 50,000 Ordinary Shares in treasury. Accordingly, the Company's issued share capital (excluding Ordinary Shares held in treasury) consists of 11,083,750 Ordinary Shares. This figure of 11,083,750 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
For further information please contact:
 



Titon Holdings plc
Keith Ritchie, Executive Chairman


 
Tel: +44 (0)1206 713821














Shore Capital (Nominated Adviser and Broker)
Dru Danford
Edward Mansfield
Daniel Bush


Tel: +44 (0)20 7408 4090













 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGIBDDRXGBGIR